Global /India /Healthcare /Medical Care Facilities /540788

Aspira Pathlab & Diagnostics Ltd.

540788 (ASPIRA)

• BSE: 540788 • Delayed

64.74INR 2%

0.6761 USD

As of 5 June 2026, Aspira Pathlab & Diagnostics Ltd. has a market cap of $6.96M USD, ranking #43081 globally and #3563 in India. It ranks #3812 in the Healthcare sector, and #459 in the Medical Care Facilities industry.

Global Rank

43081

Country Rank

3563

Sector Rank

3812

Industry Rank

459

Key Stats

Market Cap

$6.96MUSD

666.37M INR

Enterprise Value

$7.08MUSD

678.34M INR

Revenue (TTM)

$2.53MUSD

242.36M INR

EBITDA (TTM)

$218.34KUSD

20.91M INR

Net Income (TTM)

$148.29KUSD

14.2M INR

EBITDA Margin

8.6%

Profit Margin

5.9%

PE Ratio

80.0

PS Ratio

2.7

PB Ratio

4.6

EV/EBITDA

24.4

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Pankaj Shah open_in_new

Employees

141

Founded

1973

Website

aspiradiagnostics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2%	13%	16%	-7.1%	-1.3%	-4%	-3.8%	102%	112%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	540788 (ASPIRA) Aspira Pathlab & Diagnostics Ltd ISIN: INE500C01017 Shares Out.: Shares Outstanding: 10.293M¹ TV: TradingView: BSE: ASPIRA SA: Stock Analysis: BOM: 540788 YF: Yahoo Finance: 540788.BO GF: Google Finance: BOM: 540788 BA: Barron's: 540788 MS: Morningstar: XBOM: 540788	64.74 INR	TV: TradingView: BSE: ASPIRA SA: Stock Analysis: BOM: 540788 YF: Yahoo Finance: 540788.BO GF: Google Finance: BOM: 540788 BA: Barron's: 540788 MS: Morningstar: XBOM: 540788

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Aspira Pathlab & Diagnostics Ltd.

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.

Similar Companies

Industry: Medical Care Facilities (India)

Name	Market Cap (USD) diff.	PE	Country
Apollo Hospitals Enterprise Ltd. NSE: APOLLOHOSP	$11.47B 1.1T INR 165K%	60.9	India
Max Healthcare Institute Ltd. NSE: MAXHEALTH	$10.22B 978.68B INR 147K%	69.0	India
Fortis Healthcare Ltd. NSE: FORTIS	$7.37B 706.04B INR 106K%	73.6	India
Narayana Hrudayalaya Ltd. NSE: NH	$3.76B 359.57B INR 54K%	46.2	India
Global Health Ltd. NSE: MEDANTA	$3.14B 300.37B INR 45K%	58.5	India
Krishna Institute of Medical Sciences Ltd. NSE: KIMS	$2.78B 266.19B INR 40K%	88.6	India

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 3M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 1M%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 383K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 367K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 323K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 304K%	24.6	United States

chevron_leftBack